Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics

NCT04678089 · clinicaltrials.gov ↗

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Bortezomib

Interventions

DRUG: Bortezomib

Sponsor

Beijing Chao Yang Hospital